<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The transforming growth factor-β-signaling pathway has been identified as being involved in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>OBJECTIVE: The aim of this study was to determine how diet and lifestyle factors in combination with genetic variation in the transforming growth factor-β-signaling pathway alters <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> risk </plain></SENT>
<SENT sid="2" pm="."><plain>DESIGN: We used data from 2 population-based case-control studies </plain></SENT>
<SENT sid="3" pm="."><plain>PATIENTS: Participants included patients with <z:hpo ids='HP_0003003'>colon cancer</z:hpo> (n = 1574) and controls (n = 1970) and patients with <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> ( n = 791) and controls (n = 999) </plain></SENT>
<SENT sid="4" pm="."><plain>MAIN OUTCOME MEASURES: The primary outcomes measured were newly diagnosed cases of colon or <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Colon and <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> risk increased with the number of at-risk genotypes within the transforming growth factor-β-signaling pathway (OR 3.68, 95% CI 2.74,4.94 for <z:hpo ids='HP_0003003'>colon cancer</z:hpo>; OR 3.89, 95% CI 2.66,5.69 for <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e>) </plain></SENT>
<SENT sid="6" pm="."><plain>A high at-risk lifestyle score also resulted in significant increased risk with number of at-risk lifestyle factors (OR 2.99, 95% CI 2.32,3.85 for <z:hpo ids='HP_0003003'>colon cancer</z:hpo>; OR 3.37, 95% CI 2.24,5.07 for <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e>) </plain></SENT>
<SENT sid="7" pm="."><plain>The combination of high-risk genotype and high-risk lifestyle results in the greatest increase in risk (OR 7.89, 95% CI 4.45,13.96 for <z:hpo ids='HP_0003003'>colon cancer</z:hpo>; OR 8.75, 95% CI 3.66,20.89 for <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e>) </plain></SENT>
<SENT sid="8" pm="."><plain>LIMITATIONS: The study results need validation in other large studies of colon and <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: In summary, our data suggest that there is increased colon and <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> risk with increasing number of at-risk genotypes and at-risk lifestyle factors </plain></SENT>
<SENT sid="10" pm="."><plain>Although the integrity of the pathway can be diminished by a number of high-risk genotypes, this risk can be offset, in part, by maintaining a healthy lifestyle </plain></SENT>
</text></document>